Fig. 5From: Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cellsPhase contrast (PC) and fluorescence images obtained to assess the effect of 6-gingerol, doxorubicin and 6-Gin + Dox-m-HAP on a MCF-7 cells, b HEpG2 cells incubated for 72 h. Scale bar is 40 µmBack to article page